RCE 0.00% 46.5¢ recce pharmaceuticals ltd

Ann: USA Patent Granted for Recce's Antibiotics, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 431 Posts.
    lightbulb Created with Sketch. 11
    Major shareholder is Dr Graham Melrose

    Dr Graham Melrose- Executive Chairman and Chief Research Officer BSc(Hons), PhD, MBA, FRACI, CChem, FAICDFounder and inventor. Former Executive Director and Head of Research at Johnson & Johnson (Aus) in Sydney, with global responsibilities, particularly in Asia-Pacific.

    Very experienced and connected. No doubt at some stage conversations with likes of Johnson and Johnson will happen if not already
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
46.5¢
Change
0.000(0.00%)
Mkt cap ! $118.1M
Open High Low Value Volume
46.5¢ 46.5¢ 46.5¢ $2.131K 4.582K

Buyers (Bids)

No. Vol. Price($)
1 1263 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 11173 5
View Market Depth
Last trade - 12.38pm 04/12/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.